These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 5654016

  • 1. Increased survival of irradiated dogs given typhoid vaccine before or after irradiation.
    Ainsworth EJ, Mitchell FA.
    Radiat Res; 1968 Jun; 34(3):669-79. PubMed ID: 5654016
    [No Abstract] [Full Text] [Related]

  • 2. Increased survival of irradiated dogs given typhoid vaccine before or after irradiation. USNRDL-TR-67-87.
    Ainsworth EJ, Mitchell FA.
    Res Dev Tech Rep; 1967 Dec 05; ():1-24. PubMed ID: 5300783
    [No Abstract] [Full Text] [Related]

  • 3. Postirradiation leukocyte patterns in mice and dogs treated with endotoxin. USNRDL-TR-67-23.
    Ainsworth EJ, Mitchell FA.
    Res Dev Tech Rep; 1967 Jan 11; ():1-20. PubMed ID: 5298226
    [No Abstract] [Full Text] [Related]

  • 4. Decreased radiation mortality in dogs treated with typhoid-paratyphoid vaccine. USNRDL-TR-880.
    Ainsworth EJ, Mitchell FA.
    Res Dev Tech Rep; 1965 Jun 25; ():1-11. PubMed ID: 5295073
    [No Abstract] [Full Text] [Related]

  • 5. The effect of typhoid vaccine injection of partial body irradiated rats.
    Robinson E, Hochman A.
    Acta Haematol; 1965 Nov 25; 34(5):301-4. PubMed ID: 4955441
    [No Abstract] [Full Text] [Related]

  • 6. Studies on the effect of phytohemagglutinin on ascites tumor in mice.
    Robinson E, Mekori T.
    Isr J Med Sci; 1971 Jan 25; 7(1):83-9. PubMed ID: 5545772
    [No Abstract] [Full Text] [Related]

  • 7. [Changes of sugar level following intravenous typhoid vaccine].
    Hańczyc P, Tuszewska R.
    Klin Oczna; 1972 Jan 25; 42(3):879-82. PubMed ID: 5030423
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of combined use of typhoid vaccine with sexta-anatoxin and the antimetabolite methotrexate on hematopoiesis in irradiated mice].
    Deshevoĭ IuB, Martirosov.
    Patol Fiziol Eksp Ter; 1991 Jan 25; (5):24-6. PubMed ID: 1806885
    [Abstract] [Full Text] [Related]

  • 9. [Activity of leukocyte alkaline phosphatase during stimulative treatment].
    Hańczyc H, Maj-Samplawska B, Hańczyc P.
    Pol Tyg Lek; 1972 Jan 10; 27(2):48-50. PubMed ID: 5060330
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. THE DISCHARGE OF GRANULOCYTES FROM GUINEA PIG MARROW IN RESPONSE TO INTRAVENOUS T. A. B. VACCINE: A QUANTITATIVE STUDY.
    YOFFEY JM, MAKIN GS, YATES AK, DAVIS CJ, GRIFFITHS DA, WARING IS.
    Ann N Y Acad Sci; 1964 Feb 28; 113():790-9. PubMed ID: 14120526
    [No Abstract] [Full Text] [Related]

  • 12. The need for another typhoid fever vaccine.
    von Seidlein L.
    J Infect Dis; 2005 Aug 01; 192(3):357-9. PubMed ID: 15995947
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
    Dumas R, Forrat R, Lang J, Farinelli T, Loutan L.
    Adv Ther; 1997 Aug 01; 14(4):160-7. PubMed ID: 10174195
    [Abstract] [Full Text] [Related]

  • 17. [An experimental study of the possibilities of reducing the toxicity of typhoid vaccines for irradiated animals].
    Mal'tsev VN.
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Aug 01; 42(8):88-91. PubMed ID: 5873591
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Typhoid fever: from parenteral to oral vaccines].
    Lopalco PL, Prato R, Germinario C.
    Ann Ig; 2002 Aug 01; 14(3 Suppl 3):27-32. PubMed ID: 12389408
    [No Abstract] [Full Text] [Related]

  • 20. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002.
    Begier EM, Burwen DR, Haber P, Ball R, Vaccine Adverse Event Reporting System Working Group.
    Clin Infect Dis; 2004 Mar 15; 38(6):771-9. PubMed ID: 14999618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.